Welcome to Oligovax !
Oligovax is a biopharmaceutical company focused on developing innovative therapies for cancer.
The company’s leads molecule, Litenimod, is potent agonist of toll Like receptor 9 (TLR9), triggering both innate and adaptive immune response.
Such a mechanism of action provides the potential to use Litenimod either alone, or as a vaccine adjuvant, or combined to monocolonal antibodies.
Oligovax has successfully completed several clinical trials in cancer, and is conducting pre-clinical studies using Litenimod as an adjuvant in vaccine and/or immunotherapeutic approaches.
List of Vaccine Companies in Belgium:
1. GSK Vaccines (GlaxoSmithKline)
Website: GSK company website (Since a dedicated vaccines website isn't available, this points to the main GSK website)
Description: A global leader in vaccine development and production, offering a broad portfolio of vaccines for various diseases like shingles, influenza, and cervical cancer. They are known for their innovation and commitment to global health initiatives.
2. Pfizer
Website: https://www.pfizer.com/
Description: A major biopharmaceutical company with a significant presence in Belgium. They co-developed the well-known COVID-19 vaccine and are actively involved in research for new vaccines against other infectious diseases and cancers.
3. Janssen Pharmaceutica (Johnson & Johnson)
Website: https://www.janssen.com/
Description: A subsidiary of Johnson & Johnson, Janssen Pharmaceutica is a major player in vaccine development. They contribute significantly to global health by creating vaccines for various infectious diseases like HIV, Ebola, and respiratory syncytial virus (RSV).
4. UCB Pharma
Website: https://www.ucb.com/
Description: Headquartered in Belgium, UCB Pharma specializes in research, development, and commercialization of biopharmaceuticals, including vaccines for diseases like meningitis and shingles. They are also involved in developing treatments for neurological and immunological disorders.
5. PDC*line Pharma
Website: https://www.pdc-line-pharma.com/
Description: A Belgian clinical-stage biotech company with a unique approach. They are developing innovative therapeutic cancer vaccines based on a specific cell line (PDC*line) with the goal of creating personalized and more effective cancer treatments.
6. eTheRNA Immunotherapies
Website: https://www.etherna.be/
Description: A pioneer in mRNA-based immunotherapies. Located in Belgium, they are at the forefront of developing novel vaccines and treatments for cancer and infectious diseases. Their mRNA technology holds promise for creating highly targeted and adaptable therapies.
7. Univercells
Website: https://www.univercells.com/
Description: A Belgian biotech company focused on making biologics, including vaccines, more affordable and accessible. They achieve this through innovative manufacturing technologies that aim to streamline production processes.
8. Imcyse
Website: https://www.imcyse.com/
Description: This company develops specific active immunotherapies, a type of vaccine, to address severe chronic diseases. Their focus is on areas like autoimmune diseases and allergies, aiming to provide preventative and therapeutic solutions.
9. Biocartis
Website: https://www.biocartis.com/en
Description: While primarily known for their diagnostic solutions, Biocartis also plays a role in vaccine development. They create companion diagnostics, which are specialized tests used to assess the effectiveness of vaccines and other biological therapies.
10. Quality Assistance
Website: https://www.quality-assistance.com/
Description: This company provides crucial analytical support for the development and production of vaccines and other biologics. Their services ensure that these products meet strict regulatory standards for safety and efficacy.
Additional Companies to Consider:
Innogenetics: A company specializing in personalized medicine and infectious disease diagnostics, with potential involvement in vaccine development.
IBA (Ion Beam Applications): Provides particle accelerator technology used in research and pre-clinical development of vaccines and other therapies.
Gentaur Yeasen